The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ADURO BIOTECH INC COM 00739L101 15,474 2,105,282 SH   SOLE   2,105,282 0 0
CYTOMX THERAPEUTICS INC COM 23284F105 12,483 674,763 SH   SOLE   674,763 0 0
FATE THERAPEUTICS INC COM 31189P102 16,039 984,596 SH   SOLE   984,596 0 0
GALAPAGOS NV SPON ADR 36315X101 3,521 31,320 SH   SOLE   31,320 0 0
LOXO ONCOLOGY INC COM 548862101 18,674 109,312 SH   SOLE   109,312 0 0
MORPHOSYS AG SPONSORED ADS 617760202 243 9,087 SH   SOLE   9,087 0 0
MERUS N V COM N5749R100 25,577 1,295,713 SH   SOLE   1,295,713 0 0
PIERIS PHARMACEUTICALS INC COM 720795103 11,061 1,975,098 SH   SOLE   1,975,098 0 0
SPERO THERAPEUTICS INC COM 84833T103 8,405 799,691 SH   SOLE   799,691 0 0
SYNLOGIC INC COM 87166L100 14,182 998,034 SH   SOLE   998,034 0 0
SPDR SERIES TRUST S&P BIOTECH 78464A870 28,761 300,000 SH Put SOLE   0 0 300,000
SPDR SERIES TRUST S&P BIOTECH 78464A870 76,696 800,000 SH Put SOLE   0 0 800,000
XENON PHARMACEUTICALS INC COM 98420N105 7,825 592,802 SH   SOLE   592,802 0 0